Partner news
News
Partner news
Thirty Madison Raises $47M in Series B Financing From Polaris Partners, Johnson & Johnson Innovation - JJDC, Inc. and Existing Investors
Read full storyPartner news
ViaCyte and Gore Enter Clinical Phase Agreement Based on Novel Membrane Technology for PEC-Encap Product Candidate
Read full storyPartner news
Vor Biopharma Closes $110 Million Series B Financing
Read full storyPartner news
CVRx Raises $50 Million in New Equity Financing
Read full storyPartner news
Cue Health Receives FDA Emergency Use Authorization for Its Rapid, Portable, Molecular Point-of-Care COVID-19 Test
Read full storyPartner news
Cue Health Closes $100 Million Series C Financing to Support Launch of Rapid Molecular Testing Platform
Read full storyPartner news
HistoSonics Announces $40 Million Financing
Read full storyPartner news
Imec collaborates with Janssen to advance precision medicine to treat and eliminate disease
Read full storyPartner news
resTORbio and Adicet Bio Announce Merger Agreement to Advance Allogeneic Gamma Delta CAR-T Cell Therapy Technology
Read full storyPartner news
ViaCyte Announces $27 Million Financing to Advance Next Generation Cell Therapies for Diabetes
Read full storyPartner news
Inivata Announces Strategic Collaboration and Investment from NeoGenomics
Read full storyPartner news
Lava Therapeutics Announces Collaboration with Janssen to Develop Bi-specific Gamma-Delta T-cell Engager Therapeutics
Read full storyPartner news
Philogen Announces Options Exercise by Janssen
Read full storyPartner news